Skip to main content
. 2021 Jun 7;12:667336. doi: 10.3389/fimmu.2021.667336

Table 5.

Significant associations of HLA alleles and haplotypes in Italian LOMG AChR-antibody positive cases and controls ranked by odds ratios.

HLA Locus HLA alleles/haplotypes LOMG Cases Controls OR 95% CI P-value P_adj Effect
Count Fq Count Fq
DQA1~DRB1 DQA1*01:02:01:01SG~DRB1*15:01:01:01SG 12 0.102 14 0.031 3.56 1.45–8.54 9.94E−04 Risk
DRB1~DRB345 DRB1*15:01:01:01SG~DRB5*01:01:01 14 0.119 17 0.037 3.46 1.52–7.71 5.19E−04 Risk
DRB1 DRB1*15:01:01:01SG 14 0.119 17 0.037 3.46 1.52–7.71 5.19E−04 4.67E−03 Risk
DQA1 DQA1*01:02:01:01SG 14 0.119 17 0.037 3.46 1.52–7.71 5.19E−04 Risk
DRB345 DRB5*01:01:01 14 0.119 18 0.040 3.26 1.45–7.18 8.79E−04 Risk
DPA1~DPB1 DPA1*01:03:01:02~DPB1*02:01:02 10 0.085 17 0.037 2.38 0.94–5.68 0.031 Risk
DQB1~DRB1 DQB1*02:02:01:01~DRB1*07:01:01:01SG 16 0.136 32 0.070 2.07 1.02–4.05 0.023 Risk
DQB1 DQB1*02:02:01:01 17 0.144 35 0.077 2.01 1.01–3.86 0.024 Risk
DQA1~DQB1 DQA1*02:01:01:01SG~DQB1*02:02:01:01 16 0.136 33 0.073 2.00 0.99–3.91 0.030 Risk
DQA1~DRB1 DQA1*02:01:01:01SG~DRB1*07:01:01:01SG 17 0.144 38 0.084 1.84 0.93–3.50 0.048 Risk
DRB1 DRB1*07:01:01:01SG 17 0.144 38 0.084 1.84 0.93–3.50 0.048 Risk
DRB345 DRB3*01:01:02:01/02 5 0.042 54 0.119 0.33 0.10–0.84 0.015 Protective
DQA1~DRB1 DQA1*01:03:01:02SG~DRB1*13:01:01:01SG 1 0.008 27 0.059 0.14 0.00–0.84 0.022 Protective
DQB1~DRB1 DQB1*06:03:01~DRB1*13:01:01:01SG 1 0.008 27 0.059 0.14 0.00–0.84 0.022 Protective
DQA1~DQB1 DQA1*01:03:01:02SG~DQB1*06:03:01 1 0.008 27 0.059 0.14 0.00–0.84 0.022 Protective
DQA1 DQA1*01:03:01:02SG 1 0.008 27 0.059 0.14 0.00–0.84 0.022 Protective
DRB1 DRB1*13:01:01:01SG 1 0.008 30 0.066 0.12 0.00–0.74 0.014 0.124 NS
A A*24:02:01:01 4 0.034 57 0.126 0.24 0.06–0.68 4.06E−03 Protective

LOMG, late-onset Myasthenia Gravis; Fq, frequency; OR, odds ratio; CI, confidence interval; P_adj, Bonferroni corrected P-values, Only HLA-DRB1 alleles were corrected; Effect, effect of haplotype on disease outcome. NS, not significant.